Questions? Call 888-624-8373

PAPERBACK
list:$32.00
Web:$28.80
add to cart

PDF BOOK
your price: $24.50
add to cart

Rights & Permissions

topleft topright

Sources of Medical Technology: Universities and Industry (1995)
Institute of Medicine (IOM)

Page
223
bottomleft bottomright
  E-mail
 Facebook
 Digg
 Stumble
 Twitter
More

The following HTML text is provided to enhance online readability. Many aspects of typography translate only awkwardly to HTML. Please use the page image as the authoritative form to ensure accuracy.

Sources of Medical Technology: Universities and Industry

Appendix A
Workshop Agenda

THE UNIVERSITY-INDUSTRY INTERFACE AND MEDICAL INNOVATION

Sunday, February 21, 1993

2:30 p.m.

Welcome

Kenneth Shine, President, Institute of Medicine;

Introduction to the Workshop

Enriqueta Bond, Executive Officer, Institute of Medicine

Session I. Setting The Stage

Moderator:

Ken Melmon, Stanford University

Some Further Thoughts on the Origin of the Workshop

3:00

Medical Innovation and the Economic Environment

Victor Fuchs, Stanford University

3:30

R&D Management: An Academic Perspective

Stanley Cohen, Stanford University

4:00

Institutional Factors Affecting the University-Industry Interface

Niels Reimers, Technology Linkages International

4:30

Discussion
Page
223

Below are the first 10 and last 10 pages of uncorrected machine-read text (when available) of this chapter, followed by the top 30 algorithmically extracted key phrases from the chapter as a whole.
Intended to provide our own search engines and external engines with highly rich, chapter-representative searchable text on the opening pages of each chapter. Because it is UNCORRECTED material, please consider the following text as a useful but insufficient proxy for the authoritative book pages.

Do not use for reproduction, copying, pasting, or reading; exclusively for search engines.

OCR for page 223
Sources of Medical Technology: Universities and Industry Appendix A Workshop Agenda THE UNIVERSITY-INDUSTRY INTERFACE AND MEDICAL INNOVATION Sunday, February 21, 1993 2:30 p.m. Welcome Kenneth Shine, President, Institute of Medicine; Introduction to the Workshop Enriqueta Bond, Executive Officer, Institute of Medicine Session I. Setting The Stage Moderator: Ken Melmon, Stanford University Some Further Thoughts on the Origin of the Workshop 3:00 Medical Innovation and the Economic Environment Victor Fuchs, Stanford University 3:30 R&D Management: An Academic Perspective Stanley Cohen, Stanford University 4:00 Institutional Factors Affecting the University-Industry Interface Niels Reimers, Technology Linkages International 4:30 Discussion

OCR for page 224
Sources of Medical Technology: Universities and Industry 5:00 R&D Management: An Industrial Perspective Alejandro Zaffaroni, ALZA Corporation 5:30 The Evolution of Biotechnology Drugs at AMGEN and ICOS George Rathmann, ICOS Respondent: Joel Birnbaum, Hewlett-Packard 6:00 Discussion 7:00 Adjourn and Dinner Monday, February 22, 1993 8:15 a.m. Continental Breakfast Session II. Medical Device Innovation Moderator: Bill Hubbard, Former President, The Upjohn Company Respondents: Ben Holmes, Hewlett-Packard; James Benson, Health Industry Manufacturers Association; and Harvey Rudolph, Food and Drug Administration 8:45 Minimally Invasive Therapy: The Case of Endoscopy Introduction: Nathan Rosenberg, Stanford University, and Annetine Gelijns, Institute of Medicine/Columbia University Discussion 9:45 The Laser in Medicine: Birth of a New Industry Introduction: Joanne Spetz, Stanford University Discussion 10:45 Break 11:00 Cardiovascular Diagnostics Introduction: Stan Finkelstein, Massachusetts Institute of Technology, Gregory Bell, Charles River Associates, and Kevin Neels, Quintiles Discussion

OCR for page 225
Sources of Medical Technology: Universities and Industry 12:00 Medical Imaging: MRI and PET Introduction: Richard Rettig, Institute of Medicine, Holly Dawkins, Institute of Medicine, and Everette James, Vanderbilt University Discussion 1:00 Lunch 2:15 Cochlear Implants Introduction: Stuart Blume, University of Amsterdam Discussion Session III. Pharmaceutical And Biotech Innovation Moderator: Stanley Reiser, University of Texas Health Science Center Respondents: Gerald Laubach, Former President, Pfizer; Rebecca Henderson, Massachusetts Institute of Technology; James Benson, Health Industry Manufacturers Association 3:15 Purine Metabolism and the Development of Chemotherapeutic Agents Introduction: Chris Flowers and Ken Melmon, Stanford University Discussion 4:15 Break 4:30 Innovation in Biotechnology: The Case of the Small Firm Introduction: Alfonso Gambardella, Bocconi University, Milan, and Ashish Arora, Carnegie-Mellon University Discussion 5:30 Adjournment

OCR for page 226
Sources of Medical Technology: Universities and Industry Tuesday, February 23, 1993 Session III. Pharmaceutical And Biotech Innovation (continued) Moderator: Stanley Reiser, University of Texas Health Science Center Respondents: Gerald Laubach, Former President, Pfizer; Rebecca Henderson, Massachusetts Institute of Technology; James Benson, Health Industry Manufacturers Association 8:00 a.m. Innovation in Compounds to Treat Diabetes Introduction: Scott Stern, Stanford University Discussion 9:00 What Is Public? What Is Private? And What Should Be? Richard Nelson, Columbia University Discussion 9:30 General Discussion 10:00 Break 10:30 Where Do We Go From Here? Ken Melmon, Stanford University Richard Nelson, Columbia University Nathan Rosenberg, Stanford University 11:00 Adjournment

Representative terms from entire chapter:

james benson